Report overview
Alpha-fetoprotein (AFP) is the most common plasma protein produced by the liver of a fetus. When a baby is born, AFP levels are usually high; however, the level falls to quite low by age one. It is necessary for a healthy adult to have very low levels of AFP. Alpha-fetoprotein (AFP) tumor marker is used to detect and diagnose cancer of the liver, testicles, and ovaries. A blood sample is required for AFP tumor test. Tumor markers are substances produced either by cancer cells or by normal cells in response to cancer in the body.
The presence of elevated levels of AFP can be a sign of liver, ovary, or testicle cancer, as well as noncancerous liver diseases such as cirrhosis and hepatitis. According to studies, it has been proven that around 70% of patients having hepatocellular carcinoma are found to have high AFP concentrations. Moreover, 50% to 70% of patients having non-seminomatous testicular tumor showed high concentrations of AFP. Alpha-fetoprotein (AFP) tumor marker is often used in conjunction with human chorionic gonadotropin.
This report aims to provide a comprehensive presentation of the global market for Alpha-fetoprotein Tumor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-fetoprotein Tumor. This report contains market size and forecasts of Alpha-fetoprotein Tumor in global, including the following market information:
Global Alpha-fetoprotein Tumor Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Alpha-fetoprotein Tumor market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Liver Cancer Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Alpha-fetoprotein Tumor include Abbott Laboratories, Labcorp, Roche Diagnostics, Thermo Fisher Scientific and MP Biomedicals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alpha-fetoprotein Tumor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alpha-fetoprotein Tumor Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Alpha-fetoprotein Tumor Market Segment Percentages, by Type, 2023 (%)
Liver Cancer
Testes Cancer
Ovarian Cancer
Others
Global Alpha-fetoprotein Tumor Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Alpha-fetoprotein Tumor Market Segment Percentages, by Application, 2023 (%)
Screening and Early Detection
Diagnosis
Prognosis
Post Treatment Monitoring
Others
Global Alpha-fetoprotein Tumor Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Alpha-fetoprotein Tumor Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alpha-fetoprotein Tumor revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Alpha-fetoprotein Tumor revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Labcorp
Roche Diagnostics
Thermo Fisher Scientific
MP Biomedicals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Alpha-fetoprotein Tumor, market overview.
Chapter 2: Global Alpha-fetoprotein Tumor market size in revenue.
Chapter 3: Detailed analysis of Alpha-fetoprotein Tumor company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Alpha-fetoprotein Tumor in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
